ONCOLYTICS BIOTECH INC
ONCY · XNASCIK 1129928fmd_0DM01YV8P9C2K29Y2JDCEGZ1BXManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Jun 30, 2026, 15 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | 6 | 1 | 0 | 0 | 0 | – | – | – |
| Research and development | 9 | 10 | 9 | 10 | 11 | 13 | 13 | 15 | 18 | 22 |
| Operating income | (14) | (15) | (16) | (17) | (20) | (25) | (26) | (27) | (34) | (35) |
| Income before taxes | (14) | (15) | (15) | (16) | (33) | (23) | (26) | (25) | (28) | (32) |
| Income tax expense | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (14) | (15) | (16) | (17) | (33) | (23) | (26) | (25) | (28) | (32) |
| Net income | (14) | (15) | (16) | (17) | (33) | (23) | (26) | (25) | (28) | (32) |